Exploring the Connectivity of Neurodegenerative Diseases: Microglia as the Center
Yan Wang1,2,3,4, Limei Cui2,3,4, He Zhao1,2,3,4
1The Second Medical College, Binzhou Medical University, Yantai, Shandong, People's Republic of China.
Abstract:
Degenerative diseases affect people's life and health and cause a severe social burden. Relevant mechanisms of microglia have been studied, aiming to control and reduce degenerative disease occurrence effectively. This review discussed the specific mechanisms underlying microglia in neurodegenerative diseases, age-related hearing loss, Alzheimer's disease, Parkinson's disease, and peripheral nervous system (PNS) degenerative diseases. It also reviewed the studies of microglia inhibitors (PLX3397/PLX5622) and activators (lipopolysaccharide), and suggested that reducing microglia can effectively curb the genesis and progression of degenerative diseases. Finally, microglial cells' anti-inflammatory and pro-inflammatory dual role was considered the critical communication point in central and peripheral degenerative diseases. Although it is difficult to describe the complex morphological structure of microglia in a unified manner, this does not prevent them from being a target for future treatment of neurodegenerative diseases.
Insights
Reducing microglia activity can curb degenerative diseases. This review explores microglia
Area of Science:
- Neuroscience
- Immunology
- Pathology
Background:
- Degenerative diseases pose significant health and social challenges.
- Microglia, the central nervous system's immune cells, play a crucial role in disease pathogenesis.
- Understanding microglia mechanisms is key to developing effective treatments.
Purpose of the Study:
- To review the mechanisms of microglia in various degenerative diseases.
- To examine the impact of microglia inhibitors and activators.
- To highlight microglia's dual role in inflammation and disease progression.
Main Methods:
- Literature review of studies on microglia in neurodegenerative diseases, age-related hearing loss, Alzheimer's disease, Parkinson's disease, and peripheral nervous system disorders.
- Analysis of research on microglia modulators like PLX3397/PLX5622 and lipopolysaccharide.
Main Results:
- Microglia are implicated in the pathogenesis of diverse degenerative conditions.
- Inhibiting microglia (e.g., with PLX3397/PLX5622) shows potential in curbing disease genesis and progression.
- Microglia exhibit both anti-inflammatory and pro-inflammatory functions, critical in central and peripheral diseases.
Conclusions:
- Modulating microglia activity, particularly reducing their detrimental effects, offers a promising therapeutic strategy for degenerative diseases.
- Targeting microglial cells presents a viable avenue for future treatments, despite their complex nature.
More Related Videos
Related Concept Videos
Glial Cells
Nervous Tissue: Glial Cells
The CNS glial cell includes the astrocytes, the oligodendrocytes, the microglia, and the ependymal cells.
Astrocytes are star-shaped glial...
Neurogenesis and Regeneration of Nervous Tissue


